It has been shown that reduced expression of lncRNA LINC01133 is associated with aggressive tumor phenotypes and poor patient outcomes in gastric cancer, because LINC01133 inhibits gastric cancer progression and metastasis by acting as a ceRNA for miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway [53]. Here, LINC01133 is linked to gastric cancer.